Free Trial

Centene (NYSE:CNC) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Centene logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Wells Fargo raised its price target on Centene from $44 to $56 and kept an "equal weight" rating, implying about a 4.21% upside from the current price, while other banks broadly lifted targets but kept mixed neutral/hold ratings.
  • Centene posted a stronger-than-expected Q1 (EPS $3.37 vs. $2.23 forecast; revenue $49.94B vs. $47.53B), prompting analysts to raise forecasts and support higher valuation assumptions.
  • The stock traded around $53.74 (market cap ~$26.4B) with a negative trailing P/E (-4.10), a 52-week range of $25.08–$64.15, and heavy institutional ownership (~93.6%), signaling both recent volatility and significant institutional interest.
  • MarketBeat previews the top five stocks to own by June 1st.

Centene (NYSE:CNC - Get Free Report) had its price objective increased by stock analysts at Wells Fargo & Company from $44.00 to $56.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Wells Fargo & Company's price target would indicate a potential upside of 4.21% from the stock's current price.

Several other equities analysts have also commented on CNC. Morgan Stanley upped their price objective on shares of Centene from $45.00 to $50.00 and gave the stock an "equal weight" rating in a report on Wednesday. Oppenheimer restated an "outperform" rating and issued a $58.00 price objective (up from $45.00) on shares of Centene in a report on Wednesday. JPMorgan Chase & Co. decreased their price objective on shares of Centene from $45.00 to $41.00 and set a "neutral" rating on the stock in a report on Thursday, March 19th. Wall Street Zen lowered shares of Centene from a "buy" rating to a "hold" rating in a report on Sunday, February 15th. Finally, Robert W. Baird raised their price objective on shares of Centene from $36.00 to $37.00 and gave the company a "neutral" rating in a report on Wednesday, April 15th. Six analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Centene presently has an average rating of "Hold" and an average target price of $52.12.

Get Our Latest Stock Analysis on CNC

Centene Trading Up 0.1%

Shares of CNC stock traded up $0.05 during trading hours on Friday, hitting $53.74. The company had a trading volume of 766,068 shares, compared to its average volume of 6,640,064. The company's fifty day moving average is $38.91 and its 200 day moving average is $39.45. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.10. Centene has a fifty-two week low of $25.08 and a fifty-two week high of $64.15. The stock has a market capitalization of $26.43 billion, a PE ratio of -4.10, a price-to-earnings-growth ratio of 1.06 and a beta of 0.59.

Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, topping the consensus estimate of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The firm had revenue of $49.94 billion for the quarter, compared to analyst estimates of $47.53 billion. During the same period in the prior year, the business posted $2.90 EPS. The business's revenue for the quarter was up 7.1% compared to the same quarter last year. Research analysts expect that Centene will post 3.4 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CNC. UniSuper Management Pty Ltd lifted its stake in shares of Centene by 66.0% in the 3rd quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company's stock worth $3,041,000 after acquiring an additional 33,875 shares during the period. Oracle Investment Management Inc. acquired a new stake in shares of Centene in the third quarter valued at about $3,936,000. Packer & Co Ltd acquired a new stake in shares of Centene in the third quarter valued at about $50,487,000. First Citizens Bank & Trust Co. lifted its stake in shares of Centene by 122.5% in the third quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company's stock valued at $7,962,000 after purchasing an additional 122,870 shares during the period. Finally, ARGA Investment Management LP acquired a new stake in shares of Centene in the third quarter valued at about $21,485,000. 93.63% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Centene

Here are the key news stories impacting Centene this week:

  • Positive Sentiment: Q1 earnings and outlook beat expectations — Centene reported stronger-than-expected Q1 EPS and revenue and upgraded its outlook, with commentary highlighting improved margins and a brighter 2026 outlook; this is the main driver behind the rally. Centene Corp (CNC) Q1 2026 Earnings Call Highlights
  • Positive Sentiment: Big-name upgrade and bullish price-target — Truist raised its price target to $58 and kept a Buy rating, signaling confidence in the company’s recovery and margin trajectory. Truist raises PT to $58
  • Positive Sentiment: Cantor Fitzgerald upgrade and broader analyst optimism — Multiple outlets report Cantor Fitzgerald and other analysts upgrading or increasing forecasts after Q1, which bolsters investor sentiment. Cantor Fitzgerald upgrades Centene (CNC)
  • Neutral Sentiment: Selective price-target raises but mixed ratings — Several banks (UBS to $55; Deutsche Bank to $53; Mizuho/Morgan Stanley to ~$50; Jefferies to $48) raised targets but many maintained neutral/hold or equal-weight ratings, reflecting cautious optimism and leaving room for volatility. Deutsche Bank adjusts PT to $53 Mizuho adjusts PT to $50
  • Positive Sentiment: Analyst consensus revisions upward — Coverage notes and analyst model updates after Q1 have generally increased earnings/forecast estimates, supporting a higher valuation multiple relative to prior expectations. Analysts increase forecasts after Q1
  • Negative Sentiment: Consensus price target still low on some aggregators — An aggregate $42 consensus PT was reported by one outlet, signaling that some market participants still see limited upside from current levels. Centene receives $42 consensus PT
  • Negative Sentiment: Legislative/regulatory risk — H.R. 8375 (Medicare Advantage Improvement Act of 2026) proposes tighter transparency, real-time authorizations and stricter oversight of Medicare Advantage plans; if enacted, these changes could raise compliance costs or constrain plan management, a medium-term headwind for Centene. H.R. 8375 Medicare Advantage Improvement Act

Centene Company Profile

(Get Free Report)

Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.

Recommended Stories

Analyst Recommendations for Centene (NYSE:CNC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines